Keyphrases
Chronic Pancreatitis
70%
EphA2
62%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
59%
Colipase
40%
Acute Myeloid Leukemia
38%
Adipose Triglyceride Lipase
35%
Lipase
33%
Acute Recurrent Pancreatitis
32%
Pancreatic Lipase
32%
Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
30%
Acute Pancreatitis
30%
New Molecular Entity
30%
INSPPIRE
29%
Pancreatitis
28%
FDA-approved Drugs
28%
Pediatric
25%
Diffuse Large B-cell Lymphoma (DLBCL)
24%
Myelodysplastic Syndrome
23%
Relapsed or Refractory
22%
Pediatric Pancreatitis
21%
Tyrosine Kinase
19%
Confidence Interval
19%
Overall Survival
19%
Rituximab
17%
Carboxylesterase 1 (CES1)
17%
Porcine Pancreatic Lipase
16%
Overexpression
16%
Decitabine
16%
Mantle Cell Lymphoma
15%
Lymphoma Patients
15%
Phase II Study
15%
Granulocyte Colony-stimulating Factor (G-CSF)
15%
Risk Factors
14%
Plerixafor
14%
Diabetes
14%
Pancreas
13%
Tumor Cells
12%
Chemotherapy
12%
Progression-free Survival
12%
New Medicines
11%
U.S. Food
11%
Complete Remission
11%
Natural Killer Cells
11%
Fat Digestion
11%
Cytarabine
11%
Cell Adhesion
11%
Infectious Diseases
11%
Autologous Transplantation
11%
Lenalidomide
10%
Follicular Lymphoma
10%
Relapsed Lymphoma
10%
Triglycerides
10%
Complementary DNA (cDNA)
10%
Older Patients
10%
EphA2 Receptor
9%
Leukemia
9%
Tumor
9%
Hodgkin Lymphoma
9%
Integrin
9%
E-cadherin
9%
Dietary Fat
9%
Relapsed or Refractory Acute Myeloid Leukemia
9%
Ovarian Cancer
8%
Azacitidine
8%
Hazard Ratio
8%
Bile Salts
8%
Etiology
8%
Stem Cells
8%
Tyrosine Phosphorylation
8%
Phase I Study
8%
Gene Perturbation
8%
Lipase Activity
7%
Approved Drugs
7%
Overall Response Rate
7%
Stem Cell Mobilization
7%
Lipase Gene
7%
Drug Development
7%
Hematopoietic Cell Transplantation
7%
Graft-versus-host Disease (GvHD)
7%
Interleukin-15 (IL-15)
7%
Malignant Cells
7%
Epithelial Cells
7%
Pancreatic Cancer
7%
Monoclonal Antibody
7%
Pharmaceutical Companies
7%
Leukemia Patients
7%
Pharmaceutical Industry
6%
Conditioning Regimen
6%
Biotechnology Firms
6%
Lipolysis
6%
Clinical Trials
6%
Oncology
6%
Misfolding
6%
Cell Behavior
6%
Drug Discovery
6%
Cyclophosphamide
6%
New Drugs
6%
Reduced-intensity Conditioning
6%
Myeloablative Conditioning
6%
Pediatric Patients
6%
Medicine and Dentistry
Chronic Pancreatitis
60%
Pediatrics
42%
Pancreatitis
39%
Acute Myeloid Leukemia
31%
Disease
28%
Acute Pancreatitis
28%
Hematopoietic Stem Cell
27%
Cell Transplantation
27%
Overall Survival
22%
Transplantation
21%
Triacylglycerol Lipase
20%
Diffuse Large B-Cell Lymphoma
19%
Neoplasm
18%
Infection
17%
Diabetes
14%
Medicine
14%
Mantle Cell Lymphoma
13%
Plerixafor
13%
Rituximab
13%
Malignant Neoplasm
13%
Protein Tyrosine Kinase
12%
Oncology
11%
Decitabine
11%
Hodgkin's Lymphoma
11%
Ovarian Cancer
10%
Natural Killer Cell
10%
Myelodysplastic Syndrome
10%
Progression Free Survival
9%
Autotransplantation
9%
Granulocyte Colony Stimulating Factor
8%
Cytotoxic T-Cell
8%
Clinical Trial
8%
Leukemia
8%
Allogeneic Stem Cell Transplantation
8%
Autologous Stem Cell Transplantation
7%
Azacitidine
7%
Stem Cell
7%
Hematopoietic Stem Cell Transplantation
7%
Classical Hodgkin Lymphoma
7%
Lenalidomide
7%
Tumor Cell
7%
Hazard Ratio
6%
Pancreas Cancer
6%
Cytarabine
6%
T Cell
6%
Cytotoxicity
6%
Orphan
6%
Ephrin Receptor A2
6%
Cell Therapy
5%
Biological Product
5%
Tumor Progression
5%
Monoclonal Antibody
5%
Chemokine Receptor CXCR4 Antagonist
5%
Bendamustine
5%
Prostatic Intraepithelial Neoplasia
5%
Stem Cell Mobilization
5%
Follicular Lymphoma
5%
Biochemistry, Genetics and Molecular Biology
Triacylglycerol Lipase
100%
Pancreatic Lipase
100%
Colipase
36%
Triglyceride Lipase
30%
Receptor Tyrosine Kinase
27%
Mouse
20%
Messenger RNA
12%
Cadherin
11%
Tyrosine Kinase
11%
B Cell
10%
Triglyceride
10%
Tyrosine
10%
Tyrosine Phosphorylation
10%
Signal Transduction
9%
Cancer Cell
9%
Copurification
8%
Surface Property
8%
Kinase
8%
Phosphotransferase
8%
Secretion (Process)
8%
Cell Adhesion
7%
Myeloid
7%
Eicosanoid Receptor
6%
Ligand Binding
6%
C-Terminus
6%
Dietary Fat
6%
Protease
6%
Amino Acids
6%
Tumor Progression
6%
Cell Function
6%
T Cell
6%
Enzyme
5%
Monospecific Antibody
5%
Micelle
5%
Integrin
5%
Variable Number Tandem Repeat
5%
Overall Survival
5%
Genetics
5%
Disease Burden
5%
Proteotoxicity
5%
Gene Mutation
5%
Protein Misfolding
5%
Stem Cell
5%